EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Abcam's enterprise value is $5,294.5 Mil.
Abcam's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $471.5 Mil. Therefore, Abcam's EV-to-Revenue for today is 11.23.
The historical rank and industry rank for Abcam's EV-to-Revenue or its related term are showing as below:
ABCZF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 5.18 Med: 9.53 Max: 15.49
Current: 11.23
During the past 13 years, the highest EV-to-Revenue of Abcam was 15.49. The lowest was 5.18. And the median was 9.53.
ABCZF's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.68
vs ABCZF: 11.23
As of today (2024-04-26), Abcam's stock price is $22.25.
Abcam's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.03. Therefore, Abcam's PS Ratio for today is 10.96.
Abcam EV-to-Revenue Historical Data
The historical data trend for Abcam's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Abcam's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abcam's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Abcam's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Abcam's EV-to-Revenue falls into.
Abcam's current Enterprise Value is $5,294.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Abcam's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $471.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abcam's share price for today is $22.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was $2.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abcam EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Abcam's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABCZF has been successfully added to your 